Your browser doesn't support javascript.
loading
BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer.
Ehmsen, Sidse; Pedersen, Rune M; Bang, Line L; Asmussen, Anders; Kragh, Amalie; Holm, Dorte K; Sydenham, Thomas V; Jensen, Thøger G; Jeppesen, Stefan S; Frederiksen, Henrik; Andersen, Thomas E; Ditzel, Henrik J.
Afiliação
  • Ehmsen S; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark.
  • Pedersen RM; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Bang LL; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Asmussen A; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Kragh A; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Holm DK; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Sydenham TV; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Jensen TG; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
  • Jeppesen SS; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark.
  • Frederiksen H; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Andersen TE; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark. Electronic address: thandersen@health.sdu.dk.
  • Ditzel HJ; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark; OPEN-Open Patient data Exploratory Network, Odense University Hospital, O
Cancer Cell ; 41(4): 649-650, 2023 04 10.
Article em En | MEDLINE | ID: mdl-36804967

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca